NOSOCOMIAL INFECTIONS AND NOROVIRUS KAWASAKI VARIANT

A REVIEW ON EMERGENCY MANAGEMENT IN HOSPITALS

Authors

  • Gian Marco Ludovici Department of Biomedicine and Prevention, University of Rome Tor Vergata, 00133, Rome, Italy Author
  • Paola Amelia Tassi International Master Courses in Protection Against CBRNe events, Department of Industrial Engineering and School of Medicine and Surgery, University of Rome Tor Vergata, 00133, Rome, Italy Author
  • Alba Iannotti Department of Industrial Engineering, University of Rome Tor Vergata, 00133, Rome, Italy Author
  • Colomba Russo Department of Industrial Engineering, University of Rome Tor Vergata, 00133, Rome, Italy Author
  • Riccardo Quaranta National Institute for Nuclear Physics - National Laboratory of Frascati INFN-LNF, 00044, Frascati, Italy Author
  • Andrea Malizia Department of Biomedicine and Prevention, University of Rome Tor Vergata, 00133, Rome, Italy Author

DOI:

https://doi.org/10.58395/c6pp0m51

Keywords:

Nosocomial Infections, Norovirus, Emergency Management

Abstract

Nosocomial infections, also known as healthcare-associated infections (HAIs), are infections acquired during the process of receiving healthcare that were not present at the time of admission. They can occur in many areas of healthcare delivery, such as hospitals, long-term care facilities, and outpatient clinics, and can also occur after discharge. Among HAIs, nosocomial enteritis appears to be an important risk factor. However, there has been a great effort by infection prevention and control programs to develop surveillance systems and infection control methods. Viruses are the main cause of nosocomial enteritis in neonates, and rotavirus species A (RVA) and norovirus (NoV) are considered the main etiologic agents responsible for acute gastroenteritis (AGE) in hospitalized children, excluding that caused by C. difficile. Since October 2024, there has been a significant increase in cases of gastroenteritis due to a highly infectious NoV (genotype GII.17), known as the Kawasaki variant, especially in the United Kingdom, but cases are being reported throughout Europe. The hospitalization of many individuals, in a short time, due to NoV Kawasaki, in combination with the increase in hospitalizations due to typical seasonal flu, could trigger a chain reaction with a strong increase in HAIs. The aim of this work is to evaluate the current situation regarding nosocomial enteritis in the face of the new extremely infectious variant of NoV. as well as to analyze the possibility to contain the spread of a possible epidemic using a Chemical, Biological, Radiological, Nuclear, and Explosives (CBRNe) approch.

Downloads

Download data is not yet available.

References

1. Sydnor ER, Perl TM. Hospital epidemiology and infection control in acute-care settings. Clin Microbiol Rev. 2011;24(1):141-173. https://doi.org/10.1128/CMR.00027-10

2. Haque M, Sartelli M, McKimm J, Abu Bakar M. Health care-associated infections - an overview. Infect Drug Resist. 2018;11:2321-2333. https://doi.org/10.2147/IDR.S177247

3. Khabbaz R, Bell BP, Schuchat A, Ostroff SM, Moseley R, Levitt A, et al. Emerging and Reemerging Infectious Disease Threats. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 2015;158-177.e6. https://doi.org/10.1016/B978-1-4557-4801-3.00014-X

4. Gelfusa M, Murari A, Ludovici GM, Franchi C, Gelfusa C, Malizia A, et al. On the Potential of Relational Databases for the Detection of Clusters of Infection and Antibiotic Resistance Patterns. Antibiotics. 2023; 12(4):784. https://doi.org/10.3390/antibiotics12040784

5. Lian Y, Wu S, Luo L, Lv B, Liao Q, Li Z, et al. Epidemiology of Norovirus Outbreaks Reported to the Public Health Emergency Event Surveillance System, China, 2014⁻2017. Viruses. 2019;11(4):342. https://doi.org/10.3390/v11040342

6. Burke RM, Mattison CP, Marsh Z, Shioda K, Donald J, Salas SB, et al. Norovirus and Other Viral Causes of Medically Attended Acute Gastroenteritis Across the Age Spectrum: Results from the Medically Attended Acute Gastroenteritis Study in the United States. Clin Infect Dis. 2021;73(4):e913–e920. https://doi.org/10.1093/cid/ciab033

7. Chan MC, Lee N, Hung TN, Kwok K, Cheung K, Tin EK, et al. Rapid emergence and predominance of a broadly recognizing and fast-evolving norovirus GII.17 variant in late 2014. Nat Commun. 2015;6:10061. https://doi.org/10.1038/ncomms10061

8. Barclay L, Vinjé J. Increasing Predominance of Norovirus GII.17 over GII.4, United States, 2022-2025. Emerg Infect Dis. 2025;31(7):1471-1473. https://doi.org/10.3201/eid3107.250524

9. White PA. Evolution of norovirus. Clin Microbiol Infect. 2014;20(8):741-745. https://doi.org/10.1111/1469-0691.12746

10. Barclay L, Park GW, Vega E, Hall A, Parashar U, Vinjé J, et al. Infection control for norovirus. Clin Microbiol Infect. 2014;20(8):731-740. https://doi.org/10.1111/1469-0691.12674

11. Hallowell BD, Parashar UD, Hall AJ. Epidemiologic challenges in norovirus vaccine development. Hum Vaccin Immunother. 2019;15(6):1279-1283. https://doi.org/10.1080/21645515.2018.1553594

12. Vogel L. Hand sanitizers may increase norovirus risk. CMAJ. 2011;183(12):E799-E800. https://doi.org/10.1503/cmaj.109-3922

13. Malizia A, Filograna L, Sbordone FP, Ciccarese G, Carbone A, Carreri B, et al. Correction: Malizia et al. Response of a Radiology Department to the SARS-CoV-2 Pandemic: The Experience of the Hospital "Policlinico Tor Vergata" in Rome. Int. J. Environ. Res. Public Health 2021, 18, 5255. Int J Environ Res Public Health. 2022;19(8):4688. https://doi.org/10.3390/ijerph19084688

14. Qzih ES, Ahmad MM. Hospital-Based Preparedness Measures for CBRNE Disasters: A Systematic Review. Environ Health Insights. 2024;18:11786302241288859. https://doi.org/10.1177/11786302241288859

15. O'Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, et al. Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis. 2011;52(9):e162-e193. https://doi.org/10.1093/cid/cir257

16. Hungerford D, Vivancos R, Read JM, Iturriza-Gόmara M, French N, Cunliffe NA. Rotavirus vaccine impact and socioeconomic deprivation: an interrupted time-series analysis of gastrointestinal disease outcomes across primary and secondary care in the UK. BMC Med. 2018;16(1):10. https://doi.org/10.1186/s12916-017-0989-z

17. Barmpouni M, Gordon JP, Miller RL, Pritchard CRJ, Dennis JW, Grammelis V, et al. Estimating the Clinical and Economic Impact of Introducing a New Antibacterial into Greek Clinical Practice for the Management of Hospital-Acquired Infections with Limited Treatment Options. Infect Dis Ther. 2023;12(2):527-543. https://doi.org/10.1007/s40121-022-00743-4

18. Vinjé J. Advances in laboratory methods for detection and typing of norovirus. J Clin Microbiol. 2015;53(2):373-381. https://doi.org/10.1128/JCM.01535-14

19. Krenzer ME. Viral gastroenteritis in the adult population: the GI peril. Crit Care Nurs Clin North Am. 2012;24(4):541-553. https://doi.org/10.1016/j.ccell.2012.07.003

20. Manenti G, Ludovici GM, D’Amario R, Iannotti A, Russo C, Quaranta R, et al. Implementation and Application of a Contingency Plan in Case of an Unconventional CBRNe Event: A Case Study in a Hospital Facility. Defence S&T Tech Bull. 2025;18(1):21-33. 21. Ludovici GM, Tassi PA, Iannotti A, Russo C, Quaranta R, Manenti G, et al. Bioterrorism and CBRNe threats: The role of Ebola in global security. Ethics Med Public Health. 2025;33:101138. https://doi.org/10.1016/j.jemep.2025.101138

22. Cordero DA Jr. Norovirus outbreaks and the necessity of a future NoV vaccine. Ther Adv Vaccines Immunother. 2025;13:25151355251335511. https://doi.org/10.1177/25151355251335511

23. Hu L, Salmen W, Chen R, Zhou Y, Neill F, Crowe JE Jr, et al. Atomic structure of the predominant GII.4 human norovirus capsid reveals novel stability and plasticity. Nat Commun. 2022;13(1):1241. https://doi.org/10.1038/s41467-022-28757-z

24. Philip AA, Patton JT. Generation of Recombinant Rotaviruses Expressing Human Norovirus Capsid Proteins. J Virol. 2022;96(22):e0126222. https://doi.org/10.1128/jvi.01262-22

25. Cardemil CV, Parashar UD, Hall AJ. Norovirus Infection in Older Adults: Epidemiology, Risk Factors, and Opportunities for Prevention and Control. Infect Dis Clin North Am. 2017;31(4):839-870. https://doi.org/10.1016/j.idc.2017.07.012

26. Kunz JM, Lawinger H, Miko S, Gerdes M, Thuneibat M, Hannapel E, et al. Surveillance of Waterborne Disease Outbreaks Associated with Drinking Water - United States, 2015-2020. MMWR Surveill Summ. 2024;73(1):1-23. https://doi.org/10.15585/mmwr.ss7301a1

27. Anderson MS, Mosby-Tourtellot CA, Cer RZ, Crouch DJ, Underwood RS, La Claire CS, et al. Molecular Characterization of Noroviruses Causing Acute Gastroenteritis Outbreaks among US Military Recruits, 2013-2023. Emerg Infect Dis. 2024;30(14):71-79. https://doi.org/10.3201/eid3014.240307

28. Esposito S, Principi N. Norovirus Vaccine: Priorities for Future Research and Development. Front Immunol. 2020;11:1383. https://doi.org/10.3389/fimmu.2020.01383

29. Tan M. Norovirus Vaccines: Current Clinical Development and Challenges. Pathogens. 2021;10(12):1641. https://doi.org/10.3390/pathogens10121641

30. Sharma PC, McCandless M, Sontakke SP, Varshney N, Brodell RT, Kyle PB, et al. Navigating Viral Gastroenteritis: Epidemiological Trends, Pathogen Analysis, and Histopathological Findings. Cureus. 2024;16(5):e61197. https://doi.org/10.7759/cureus.61197

31. Struelens MJ, Ludden C, Werner G, Sintchenko V, Jokelainen P, Ip M. Real-time genomic surveillance for enhanced control of infectious diseases and antimicrobial resistance. Front Sci. 2024;2:1298248. doi: https://doi.org/10.3389/fsci.2024.1298248

32. McDougall R, Warton C, Chew C, Delany C, Ko D, Massie J. Visitor restrictions in hospitals during infectious disease outbreaks: An ethical approach to policy development and requests for exemptions. Bioethics. 2023;37(7):715-724. https://doi.org/10.1111/bioe.13188

33. Lassi N, Jiang S, Du Y. The Legal and Ethical Dimensions of Hospital Visitation Bans in the COVID-19 Era. Healthcare (Basel). 2025;13(3):288. https://doi.org/10.3390/healthcare13030288

34. Wong A, Zoller C, Fouda A, Paolucci F. Are we past the COVID-19 Pandemic? Insights from Singapore. Health Policy Technol. 2024;13(1):100779. https://doi.org/10.1016/j.hlpt.2023.100779

35. Ruis C, Lindesmith LC, Mallory ML, Brewer-Jensen PD, Bryant JM, Costantini V, et al. Preadaptation of pandemic GII.4 noroviruses in unsampled virus reservoirs years before emergence. Virus Evol. 2020;6(2):veaa067. https://doi.org/10.1093/ve/veaa067

36. Omatola CA, Mshelbwala PP, Okolo MO, Onoja AB, Abraham JO, Adaji DM, et al. Noroviruses: Evolutionary Dynamics, Epidemiology, Pathogenesis, and Vaccine Advances-A Comprehensive Review. Vaccines (Basel). 2024;12(6):590. https://doi.org/10.3390/vaccines12060590

Downloads

Published

2025-09-15

Issue

Vol. 53 No. 2 (2025)

Section

Articles

License

Copyright (c) 2025 Gian Marco Ludovici, Paola Amelia Tassi, Alba Iannotti, Colomba Russo, Riccardo Quaranta, Andrea Malizia (Author)

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

CC-BY 4.0

How to Cite

(1)
Ludovici, G. M.; Tassi, P. A.; Iannotti, A.; Russo, C.; Quaranta, R.; Malizia, A. NOSOCOMIAL INFECTIONS AND NOROVIRUS KAWASAKI VARIANT: A REVIEW ON EMERGENCY MANAGEMENT IN HOSPITALS. Probl Infect Parasit Dis 2025, 53 (2), 5-10. https://doi.org/10.58395/c6pp0m51.